CDER Updates Policies on Expedited Review of Prior Approval Supplements

International Pharmaceutical Regulatory Monitor
A A
CDER released a revised Manual of Policies and Procedures on expedited reviews of prior approval supplements for new drug and biologics license applications that involve chemistry, manufacturing and controls changes.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor